Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research focused on Parkin and Dopaminergic, with related work in MPTP, Neuroprotection, Synucleinopathies. Notable publications include 'Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease', 'Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration', and 'The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease'.
Gut microbial production of imidazole propionate drives Parkinson’s pathologies
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism
PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival
Activation of tyrosine kinase c-Abl contributes to α-synuclein–induced neurodegeneration
Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration
The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss